NASDAQ: RADX
Radiopharm Theranostics Ltd Stock Forecast, Predictions & Price Target

Analyst price target for RADX

Based on 1 analyst offering 12 month price targets for Radiopharm Theranostics Ltd

Min Forecast
$16.00+300%
Avg Forecast
$16.00+300%
Max Forecast
$16.00+300%

Should I buy or sell RADX stock?

Based on 1 analyst offering ratings for Radiopharm Theranostics Ltd.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their RADX stock forecasts and price targets.

RADX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-16Find Out Why

1 of 1

RADX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
RADX$4.00$16.00+300.00%Strong Buy
LSTA$3.15N/AN/A
TPST$1.99$11.00+452.76%Buy
NEUP$5.31$7.00+31.83%Buy
KYNB$6.95N/AN/A

Radiopharm Theranostics Stock Forecast FAQ

Is Radiopharm Theranostics Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: RADX) stock is to Strong Buy RADX stock.

Out of 1 analyst, 1 (100%) are recommending RADX as a Strong Buy, 0 (0%) are recommending RADX as a Buy, 0 (0%) are recommending RADX as a Hold, 0 (0%) are recommending RADX as a Sell, and 0 (0%) are recommending RADX as a Strong Sell.

If you're new to stock investing, here's how to buy Radiopharm Theranostics stock.

What is RADX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year RADX price target, the average RADX price target is $16.00, with the highest RADX stock price forecast at $16.00 and the lowest RADX stock price forecast at $16.00.

The Wall Street analyst predicted that Radiopharm Theranostics's share price could reach $16.00 by Dec 16, 2026. The average Radiopharm Theranostics stock price prediction forecasts a potential upside of 300% from the current RADX share price of $4.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.